UK Companies House feature
SHANDON DIAGNOSTICS LIMITED
Profile
- Company number
- 00330973
- Status
- Active
- Incorporation
- 1937-08-24
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have prepared the financial statements on the going concern basis as they do not intend to liquidate the Company or to cease its operations, and as they have concluded that the Company's financial position means that this is realistic They have also concluded that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements ("the going concern period").”
Subsidiaries
- Epredia Belgium BV · 100% held · Belgaum · Manufacture of medical instruments
- Epredia Hong Kong Limited · 100% held · Hong Kong · Manufacture of medical instruments
- Epredia Hungary KFT · 100% held · Hungary · Manufacture of medical instruments
- Epredia India Private Limited · 99.9% held · India · Dormant
- Epredia Italy S.R.L. · 100% held · Italy · Manufacture of medical instruments
- Shandon Diagnostic Sdn Bhd. · 100% held · Malaysia · Dormant
- Epredia Netherlands B.V. · 100% held · Netherlands · Manufacture of medical instruments
- Epredia Singapore Pte Ltd · 100% held · Singapore · Manufacture of medical instruments
- Epredia Taiwan Limited · 100% held · Taiwan · Dormant
Significant events
- “The E1000 Dx Digital Pathology Solution (E1000 Dx) received clearance from the US Food and Drug Administration early March 2025 and that allows the company to start selling these instruments in the USA to the clinical market.”
- “The company's immediate parent company "Epredia Holdings Limited" has agreed to irrevocable and unconditionally release and discharge the loan balance amounting to £34,591,019 and trade payables balance of £8,265,979 as capital contribution and release the company from all its present and future obligations, liabilities arising in connection with the loan and trade payables balance.”
- “The company received a loan of £2.3 million on 15 May 2025 from Epredia Holdings Limited.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 41 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KING, Christopher Allan | Director | 2022-11-10 | Nov 1970 | American |
| LYNUM, Steven | Director | 2022-08-31 | Mar 1969 | Canadian |
| WEIR, Ian | Director | 2020-11-03 | Nov 1966 | British |
Show 41 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GREGG, Rhona | Secretary | 2015-09-10 | 2019-06-28 |
| HICKEY, Damian Joseph | Secretary | 1997-11-25 | 2004-02-18 |
| OSTLER, John Ramsdell | Secretary | — | 1997-11-25 |
| WARD, Nicola Jane | Secretary | 2004-02-18 | 2014-12-18 |
| A G SECRETARIAL LIMITED | Corporate Secretary | 2004-02-18 | 2009-10-31 |
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2009-11-01 | 2019-06-28 |
| ALMOND, James Michael | Director | — | 1993-01-15 |
| ATKINSON, Richard Henry | Director | — | 1995-05-26 |
| BLAND, Francis Christopher Buchan, Sir | Director | — | 1997-03-12 |
| BROUGHAM, Peter David | Director | 1994-05-09 | 1995-09-29 |
| BUSH, Allan Edward | Director | — | 1997-12-19 |
| CAMERON, Euan Daney Ross | Director | 2018-10-31 | 2019-06-28 |
| CHANG, Roy Jae Hun | Director | 2022-09-07 | 2022-10-24 |
| COLEY, James Robert Ewen | Director | 2004-02-18 | 2012-04-18 |
| CONSTANTINE, Simon John | Director | 1995-05-26 | 1997-09-01 |
| COSGROVE, Raymond Francis, Dr | Director | — | 1993-01-29 |
| DOLPHIN, Robert John, Doctor | Director | 1994-05-09 | 1998-01-05 |
| GRAND, Emmanuel Nicolas | Director | 2019-06-28 | 2020-08-11 |
| GRANT, Lucie Mary Katja | Director | 2013-02-07 | 2019-06-28 |
| HARTMAN, Cory Whitty | Director | 2020-08-11 | 2022-11-28 |
| HERMETSCHWEILER, Ursula Erika | Director | 2019-06-28 | 2020-08-11 |
| HICKEY, Damian Joseph | Director | 1998-01-05 | 2006-12-07 |
| INCE, Nicholas | Director | 2015-09-10 | 2018-10-31 |
| JACOBSEN, Michael Allan | Director | 2022-09-07 | 2023-05-04 |
| KEY, Brian Alan, Dr | Director | — | 1997-07-04 |
| LEE, Jeremy Stephen William | Director | 1993-06-24 | 1997-11-07 |
| MADDIX, Colin | Director | 1993-05-01 | 2001-11-01 |
| MAROTTA, John Patrick | Director | 2020-08-11 | 2021-09-23 |
| MOODIE, Iain Alasdair Keith | Director | 2012-04-18 | 2013-02-07 |
| NISHIKAWA, Kotaro | Director | 2019-06-28 | 2020-08-11 |
| NORMAN, David John | Director | 2015-11-16 | 2019-06-28 |
| OATRIDGE, Nicholas James | Director | 1994-04-18 | 1997-09-12 |
| PERKINS, James Ian | Director | 2004-02-18 | 2004-12-01 |
| POST, James | Director | 2019-06-28 | 2020-08-11 |
| ROSSWAG, Christof | Director | 2019-06-28 | 2022-08-31 |
| SENIOR, Martin Russell | Director | — | 1993-08-25 |
| SMITH, Anthony Hugh | Director | 2018-11-12 | 2019-06-28 |
| SWEENEY, John | Director | 2021-09-23 | 2022-08-31 |
| WHEELER, Kevin Neil | Director | 2004-02-18 | 2015-11-16 |
| WILSON, Crawford John | Director | 1993-11-15 | 2008-03-19 |
| WRIGHT, Katie Rose | Director | 2010-12-01 | 2015-09-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Phc Holdings Corporation | Corporate entity | Significant influence | 2021-10-14 | Active |
| Kkr & Co. Inc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-06-28 | Ceased 2021-10-14 |
| Thermo Fisher Scientific Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2019-06-28 |
Filing timeline
Last 20 of 253 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-04 | AA | accounts | accounts with accounts type full |
| 2025-05-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-11-27 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2024-11-21 | AA | accounts | accounts with accounts type full |
| 2024-05-28 | AA | accounts | accounts with accounts type full |
| 2024-05-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-06-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-05-17 | TM01 | officers | termination director company with name termination date |
| 2023-01-09 | AA | accounts | accounts with accounts type full |
| 2022-11-29 | TM01 | officers | termination director company with name termination date |
| 2022-11-14 | AP01 | officers | appoint person director company with name date |
| 2022-10-27 | TM01 | officers | termination director company with name termination date |
| 2022-09-08 | AP01 | officers | appoint person director company with name date |
| 2022-09-08 | AP01 | officers | appoint person director company with name date |
| 2022-09-02 | TM01 | officers | termination director company with name termination date |
| 2022-09-02 | TM01 | officers | termination director company with name termination date |
| 2022-09-02 | AP01 | officers | appoint person director company with name date |
| 2022-07-22 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2022-06-01 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-06-01 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.